Tradestie Institutional Equity Comparison Engine
MEDX vs AADR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MEDX Overall Edge
MEDX Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Horizon Kinetics Medical ETF (MEDX) driven by superior Momentum & Technical. Fundamentally, MEDX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AADR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MEDX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AADR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MEDX N/M vs AADR N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
MEDX
1Y +19.2% vs -9.7% ยท 52W Pos 89% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MEDX
NASDAQ
Horizon Kinetics Medical ETF
Institutional Equity
$37.85
-0.42% 1D
Market Cap
N/A
1M Return
+5.14%
1Y Return
+19.21%
Forward P/E
N/M
Unified AI Score
46.0 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 46.0
AADR
NASDAQ
AdvisorShares Dorsey Wright ADR ETF
Institutional Equity
$77.92
-1.77% 1D
Market Cap
N/A
1M Return
-2.99%
1Y Return
-9.72%
Forward P/E
N/M
Unified AI Score
57.7 / 100
HOLD
Tech 73.0
Fund 59.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MEDX +19.21%
AADR -9.72%
Spread: +25.97 pp (MEDX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MEDX TTM Op. Margin: N/A
AADR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MEDX vs AADR. Trailing 12-month operating profitability (MEDX N/A vs AADR N/A) and valuation multiples (MEDX N/M vs AADR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MEDX | AADR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 89% ($32โ$39) | 6% ($77โ$98) | Stronger Trend | MEDX |
| Beta / 30D Volatility Risk Regime | 0.32ฮฒ ยท 19% Vol | 1.12ฮฒ ยท 23% Vol | Lower Realized Risk | MEDX |
| Unified Institutional Score Composite Signal | 46.0 / 100 (HOLD) | 57.7 / 100 (HOLD) | Higher Composite | AADR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MEDX vs AADR Buy Guide
MEDX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AADR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MEDX nor AADR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.